Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-21

Clinical Trial Update: S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing two fixed-dose regimens in essential hypertension: S-amlodipine with chlorthalidone versus S-amlodipine with telmisartan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorthalidone (chlorthalidone)
  • S-amlodipine (S-amlodipine)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Essential Hypertension | Phase 4 | Status: UNKNOWN